Puma Biotechnology, Inc. (PBYI)
9.55
+0.14
(+1.49%)
USD |
NASDAQ |
Sep 04, 16:00
9.55
0.00 (0.00%)
After-Hours: 20:00
Puma Biotechnology Total Liabilities (Quarterly) : 54.19M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 54.19M |
| March 31, 2026 | 64.28M |
| December 31, 2025 | 87.33M |
| September 30, 2025 | 87.59M |
| June 30, 2025 | 90.20M |
| March 31, 2025 | 99.07M |
| December 31, 2024 | 122.62M |
| September 30, 2024 | 149.63M |
| June 30, 2024 | 156.49M |
| March 31, 2024 | 163.17M |
| December 31, 2023 | 177.09M |
| September 30, 2023 | 164.86M |
| June 30, 2023 | 170.10M |
| March 31, 2023 | 170.41M |
| December 31, 2022 | 200.45M |
| September 30, 2022 | 176.62M |
| June 30, 2022 | 173.91M |
| March 31, 2022 | 193.54M |
| December 31, 2021 | 229.03M |
| September 30, 2021 | 237.21M |
| June 30, 2021 | 230.53M |
| March 31, 2021 | 242.22M |
| December 31, 2020 | 250.17M |
| September 30, 2020 | 262.15M |
| June 30, 2020 | 240.41M |
| Date | Value |
|---|---|
| March 31, 2020 | 216.15M |
| December 31, 2019 | 217.44M |
| September 30, 2019 | 214.86M |
| June 30, 2019 | 218.09M |
| March 31, 2019 | 287.88M |
| December 31, 2018 | 224.82M |
| September 30, 2018 | 184.81M |
| June 30, 2018 | 189.32M |
| March 31, 2018 | 112.18M |
| December 31, 2017 | 112.22M |
| September 30, 2017 | 102.69M |
| June 30, 2017 | 52.71M |
| March 31, 2017 | 49.23M |
| December 31, 2016 | 42.97M |
| September 30, 2016 | 42.88M |
| June 30, 2016 | 43.82M |
| March 31, 2016 | 40.23M |
| December 31, 2015 | 33.84M |
| September 30, 2015 | 26.78M |
| June 30, 2015 | 27.58M |
| March 31, 2015 | 27.55M |
| December 31, 2014 | 45.71M |
| September 30, 2014 | 30.45M |
| June 30, 2014 | 29.04M |
| March 31, 2014 | 21.47M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Arcutis Biotherapeutics, Inc. | 267.96M |
| ACADIA Pharmaceuticals, Inc. | 436.29M |
| Alnylam Pharmaceuticals, Inc. | 4.205B |
| Anika Therapeutics, Inc. | 46.19M |
| Savara, Inc. | 48.48M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.74M |
| Shareholders Equity (Quarterly) | 138.54M |
| Debt to Equity Ratio | 0.0348 |
| Current Ratio | 2.912 |
| Net Debt Paydown Yield | 2.75% |